AU3274199A - Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases - Google Patents

Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases

Info

Publication number
AU3274199A
AU3274199A AU32741/99A AU3274199A AU3274199A AU 3274199 A AU3274199 A AU 3274199A AU 32741/99 A AU32741/99 A AU 32741/99A AU 3274199 A AU3274199 A AU 3274199A AU 3274199 A AU3274199 A AU 3274199A
Authority
AU
Australia
Prior art keywords
triazolo
treatment
chronic obstructive
obstructive pulmonary
pulmonary diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32741/99A
Inventor
Yasuko Ashida
Yasuhiko Kawano
Kenichirou Kiyoshima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU3274199A publication Critical patent/AU3274199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU32741/99A 1998-03-04 1999-03-03 Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases Abandoned AU3274199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10-51583 1998-03-04
JP5158398 1998-03-04
PCT/JP1999/001010 WO1999044611A1 (en) 1998-03-04 1999-03-03 Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases

Publications (1)

Publication Number Publication Date
AU3274199A true AU3274199A (en) 1999-09-20

Family

ID=12890971

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32741/99A Abandoned AU3274199A (en) 1998-03-04 1999-03-03 Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases

Country Status (4)

Country Link
EP (1) EP1059924A1 (en)
AU (1) AU3274199A (en)
CA (1) CA2319426A1 (en)
WO (1) WO1999044611A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3200B (en) * 1992-03-18 1995-03-27 Takeda Chemical Industries Ltd Triazolopyridazine methodfor production thereof and use
TW304878B (en) * 1993-09-21 1997-05-11 Takeda Pharm Industry Co Ltd
AU695377B2 (en) * 1994-09-16 1998-08-13 Takeda Chemical Industries Ltd. Triazolopyridazines process and intermediates for their preparation and their use as medicaments

Also Published As

Publication number Publication date
CA2319426A1 (en) 1999-09-10
EP1059924A1 (en) 2000-12-20
WO1999044611A1 (en) 1999-09-10

Similar Documents

Publication Publication Date Title
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
AU1520699A (en) Methods for treatment of disorders of cardiac contractility
AUPP609198A0 (en) Use of non-peptidyl compounds for the treatment of insulin related ailments
AU1041599A (en) Therapeutic uses of triazolo-pyridazine derivatives
AU6910600A (en) Methods for the treatment of mental disorders
AU7622000A (en) Compounds for the treatment of viral-mediated diseases
AU9551298A (en) Use of coumarin derivatives for the treatment of digestive tract disorders
AU6083899A (en) Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
AU6330999A (en) Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
AU2001260834A1 (en) The treatment of herpes
AU2001293891A1 (en) New combination for the treatment of asthma
IL143636A0 (en) Diazepinoindoles for the treatment of chronic obstructive pulmonary disease
AU5262200A (en) Arrangement in ventilatory treatment of the lungs
AU1878201A (en) Composition for the treatment of damaged tissue
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU4976599A (en) Method for treatment of fibrosis related diseases by the administration of prostacyclin derivatives
AU2002249947A1 (en) Inhibition of protein-phosphatases for the treatment of heart failure
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
AU6331099A (en) Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU3274199A (en) Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases
AU5553200A (en) Process for the preparation of paroxetine and structurally related compounds
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease
AU4145999A (en) Topical drug for the treatment of viral infections
AU1522101A (en) Heparanase inhibitors for the treatment of heart failure

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase